Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Breast Cancer

  Free Subscription


06.02.2012

1 Am J Surg Pathol
1 Ann Oncol
1 Ann Surg Oncol
3 Anticancer Res
4 BMC Cancer
2 BMJ
5 Br J Cancer
2 Breast Cancer
4 Breast Cancer Res
7 Breast Cancer Res Treat
2 Breast J
3 Cancer
2 Cancer Res
1 Carcinogenesis
1 Clin Cancer Res
1 CMAJ
1 Eur J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Clin Invest
1 J Clin Oncol
2 J Nucl Med
1 J Pathol
1 JAMA
1 N Engl J Med
4 Oncogene
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Radiother Oncol
3 Science


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. TROXEL DB
    Trends in pathology malpractice claims.
    Am J Surg Pathol. 2012;36:e1-5.
    PubMed     Text format     Related articles    Abstract available



    Ann Oncol

  2. PETIT JY , Lohsiriwat V, Rietjens M
    Reply to about locoregional recurrence risk after lipofilling in breast cancer patients.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles   



    Ann Surg Oncol

  3. WHITWORTH PW
    Intact Percutaneous Excision (IPEX) for Definitive Diagnosis of High-Risk Breast Lesions.
    Ann Surg Oncol. 2011;18:3095.
    PubMed     Text format     Related articles    Abstract available



    Anticancer Res


  4. Targeted therapies in breast cancer.
    Anticancer Res. 2012;32:719.
    PubMed     Text format     Related articles   


  5. WAZIR U , Jiang WG, Sharma AK, Mokbel K, et al
    The mRNA Expression of DAP3 in Human Breast Cancer: Correlation with Clinicopathological Parameters.
    Anticancer Res. 2012;32:671-4.
    PubMed     Text format     Related articles    Abstract available


  6. LIN CY , Ho CM, Bau DT, Yang SF, et al
    Evaluation of Breast Cancer Susceptibility Loci on 2q35, 3p24, 17q23 and FGFR2 Genes in Taiwanese Women with Breast Cancer.
    Anticancer Res. 2012;32:475-482.
    PubMed     Text format     Related articles    Abstract available



    BMC Cancer

  7. WU ZS , Wang CQ, Xiang R, Liu X, et al
    Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
    BMC Cancer. 2012;12:51.
    PubMed     Text format     Related articles    Abstract available


  8. WU QW , She HQ, Liang J, Huang YF, et al
    Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
    BMC Cancer. 2012;12:47.
    PubMed     Text format     Related articles    Abstract available


  9. AL SORKHY M , Ferraiuolo RM, Jalili E, Malysa A, et al
    The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
    BMC Cancer. 2012;12:45.
    PubMed     Text format     Related articles    Abstract available


  10. MIEOG JS , de Kruijf EM, Bastiaannet E, Kuppen PJ, et al
    Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
    BMC Cancer. 2012;12:42.
    PubMed     Text format     Related articles    Abstract available



    BMJ

  11. WEEDON-FEKJAER H , Bakken K, Vatten LJ, Tretli S, et al
    Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
    BMJ. 2012;344:e299.
    PubMed     Text format     Related articles    Abstract available


  12. MICHELS KB
    The rise and fall of breast cancer rates.
    BMJ. 2012;344:d8003.
    PubMed     Text format     Related articles   



    Br J Cancer

  13. KWON MJ , Park S, Choi JY, Oh E, et al
    Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.
    Br J Cancer. 2012 Jan 31. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available


  14. YAGHJYAN L , Mahoney MC, Succop P, Wones R, et al
    Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.
    Br J Cancer. 2012 Jan 26. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available


  15. PARKIN DM
    15. Cancers attributable to reproductive factors in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S73-6.
    PubMed     Text format     Related articles   


  16. PARKIN DM
    10. Cancers attributable to exposure to hormones in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S42-8.
    PubMed     Text format     Related articles   


  17. PARKIN DM
    9. Cancers attributable to inadequate physical exercise in the UK in 2010.
    Br J Cancer. 2011;105 Suppl 2:S38-41.
    PubMed     Text format     Related articles   



    Breast Cancer

  18. NAKASHIMA K , Moriya T
    Comprehensive ultrasound diagnosis for intraductal spread of primary breast cancer.
    Breast Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available


  19. KASAHARA Y , Kawai M, Tsuji I, Tohno E, et al
    Harms of screening mammography for breast cancer in Japanese women.
    Breast Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res

  20. PEREZ-GARCIA J , Cortes J
    Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
    Breast Cancer Res. 2012;14:104.
    PubMed     Text format     Related articles    Abstract available


  21. SUN Y , Rowehl LM, Huang L, Machenzie GG, et al
    Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
    Breast Cancer Res. 2012;14:R20.
    PubMed     Text format     Related articles    Abstract available


  22. HAWKINS OE , Richmond A
    The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.
    Breast Cancer Res. 2012;14:103.
    PubMed     Text format     Related articles    Abstract available


  23. CHAY WY , Ong WS, Tan PH, Leo NQ, et al
    Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
    Breast Cancer Res. 2012;14:R19.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res Treat

  24. OUT AA , Wasielewski M, Huijts PE, van Minderhout IJ, et al
    MUTYH gene variants and breast cancer in a Dutch case-control study.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  25. MU L , Tuck D, Katsaros D, Lu L, et al
    Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  26. GRAVGAARD KH , Lyng MB, Laenkholm AV, Sokilde R, et al
    The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  27. WU AH , Lorizio W, Tchu S, Lynch K, et al
    Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  28. GIRGERT R , Emons G, Grundker C
    Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  29. KILBREATH SL , Refshauge KM, Beith JM, Ward LC, et al
    Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  30. WIGERTZ A , Ahlgren J, Holmqvist M, Fornander T, et al
    Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available



    Breast J

  31. VANLEMMENS L , Christophe V, Fournier E, Dauchy S, et al
    The Quality of Life of Young Women with Nonmetastatic Breast Cancer and their Partners': Specific Needs Require Development of Specific Questionnaires for Each of them.
    Breast J. 2012 Jan 29. doi: 10.1111/j.1524-4741.2011.01218.
    PubMed     Text format     Related articles   


  32. OLIVEIRA RODRIGUES FF , Dos Santos RE, de Oliveira AL, de Lima Rozenowicz R, et al
    Prognostic Assessment of Polymorphisms of the MDR-1 and GSTP1 Genes in Patients with Stage II and III Breast Cancer Submitted to Neoadjuvant Chemotherapy.
    Breast J. 2012 Jan 27. doi: 10.1111/j.1524-4741.2011.01211.
    PubMed     Text format     Related articles   



    Cancer

  33. JAIN S , Coulter I, Mills P
    Reply to complementary medicine for fatigue and cortisol variability in breast cancer survivors.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27421.
    PubMed     Text format     Related articles   


  34. COYNE JC , Johansen C, Gorski D
    Complementary medicine for fatigue and cortisol variability in breast cancer survivors.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27415.
    PubMed     Text format     Related articles   


  35. MORROW PK , Murthy RK, Ensor JD, Gordon GS, et al
    An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.26730.
    PubMed     Text format     Related articles    Abstract available



    Cancer Res

  36. NAGAHASHI M , Ramachandran S, Kim EY, Allegood JC, et al
    Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Cancer Res. 2012;72:726-35.
    PubMed     Text format     Related articles    Abstract available


  37. BARONE I , Catalano S, Gelsomino L, Marsico S, et al
    Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    Carcinogenesis

  38. HU Z , Dong J, Wang LE, Ma H, et al
    Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Carcinogenesis. 2012.
    PubMed     Text format     Related articles    Abstract available



    Clin Cancer Res

  39. DONOGHUE M , Lemery SJ, Yuan W, He K, et al
    Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a "Physicans' Choice" Control Arm in a Randomized Approval Trial.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    CMAJ

  40. CARROLL JC , Heisey R, Warner E
    Family history and breast cancer.
    CMAJ. 2012.
    PubMed     Text format     Related articles   



    Eur J Cancer

  41. BENDIFALLAH S , Defert S, Chabbert-Buffet N, Maurin N, et al
    Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study.
    Eur J Cancer. 2012;48:30-6.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  42. WALKER GV , Niikura N, Yang W, Rohren E, et al
    Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field Designs.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available


  43. PARK CK , Pritz J, Zhang GG, Forster KM, et al
    Validating fiducial markers for image-guided radiation therapy for accelerated partial breast irradiation in early-stage breast cancer.
    Int J Radiat Oncol Biol Phys. 2012;82:e425-31.
    PubMed     Text format     Related articles    Abstract available


  44. PERGOLIZZI S , Santacaterina A
    In Regard to "Breast Cancer Recurrent on Supraclavicular Node(s): What Is the Treatment?" (Int J Radiat Oncol Biol Phys 2011;80:1453-1457).
    Int J Radiat Oncol Biol Phys. 2012;82:1058-9.
    PubMed     Text format     Related articles   



    J Clin Invest

  45. LI J , Karaplis AC, Huang DC, Siegel PM, et al
    PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.
    J Clin Invest. 2011;121:4655-69.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  46. HARBECK N , Rody A
    Lost in Translation? Estrogen Receptor Status and Endocrine Responsiveness in Breast Cancer.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   



    J Nucl Med

  47. LIEBERMAN BP , Ploessl K, Wang L, Qu W, et al
    PET of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available


  48. OUDE MUNNINK TH , Arjaans ME, Timmer-Bosscha H, Schroder CP, et al
    PET with the 89Zr-Labeled Transforming Growth Factor-beta Antibody Fresolimumab in Tumor Models.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Pathol

  49. LE QUESNE J , Jones J, Warren J, Dawson SJ, et al
    Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridisation analysis of micro-RNA expression in arrays of archival tumour tissue.
    J Pathol. 2012 Jan 4. doi: 10.1002/path.3983.
    PubMed     Text format     Related articles    Abstract available



    JAMA

  50. MORROW M , Katz SJ
    The challenge of developing quality measures for breast cancer surgery.
    JAMA. 2012;307:509-10.
    PubMed     Text format     Related articles   



    N Engl J Med

  51. MONTERO AJ , Vogel C
    Fighting fire with fire: rekindling the bevacizumab debate.
    N Engl J Med. 2012;366:374-5.
    PubMed     Text format     Related articles   



    Oncogene

  52. SMITH AL , Iwanaga R, Drasin DJ, Micalizzi DS, et al
    The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.
    PubMed     Text format     Related articles    Abstract available


  53. URSINI-SIEGEL J , Hardy WR, Zheng Y, Ling C, et al
    The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.
    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.
    PubMed     Text format     Related articles    Abstract available


  54. MARUANI DM , Spiegel TN, Harris EN, Shachter AS, et al
    Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available


  55. BELGUISE K , Milord S, Galtier F, Moquet-Torcy G, et al
    The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.
    Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available



    PLoS One

  56. OHSHIRO K , Schwartz AM, Levine PH, Kumar R, et al
    Alternate Estrogen Receptors Promote Invasion of Inflammatory Breast Cancer Cells via Non-Genomic Signaling.
    PLoS One. 2012;7:e30725.
    PubMed     Text format     Related articles    Abstract available


  57. CHAN HS , Chang SJ, Wang TY, Ko HJ, et al
    Serine Protease PRSS23 Is Upregulated by Estrogen Receptor alpha and Associated with Proliferation of Breast Cancer Cells.
    PLoS One. 2012;7:e30397.
    PubMed     Text format     Related articles    Abstract available



    Proc Natl Acad Sci U S A

  58. GUPTA S
    Profile of V. Craig Jordan.
    Proc Natl Acad Sci U S A. 2011;108:18876-8.
    PubMed     Text format     Related articles   



    Radiology

  59. JORGENSEN KJ , Keen JD, Zahl PH, Gotzsche PC, et al
    The two-county breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening.
    Radiology. 2012;262:729-30.
    PubMed     Text format     Related articles   



    Radiother Oncol

  60. BUDRUKKAR A , Jagtap V, Kembhavi S, Munshi A, et al
    Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy.
    Radiother Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Science

  61. EVAN G
    Cancer. Taking a back door to target Myc.
    Science. 2012;335:293-4.
    PubMed     Text format     Related articles   


  62. COUZIN-FRANKEL J
    Clinical trials. Experimental cancer therapies move to the front line.
    Science. 2012;335:282-3.
    PubMed     Text format     Related articles   


  63. KESSLER JD , Kahle KT, Sun T, Meerbrey KL, et al
    A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
    Science. 2012;335:348-53.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: